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Early fusion of craniosynostosis may occur prior to birth or afterwards during cranial vault 
growth. The cause of craniosynostosis may be due to genetic maturations and/or environmental 
influences. Many reports show environmental influences increasing the penetrance or expression 
of craniosynostosis. The purpose of this study is to identify the environmental influences of post-
natal administration of tri-iodothyronine (T3) in rabbits that demonstrate familial delayed onset 
craniosynostosis, and identify a possible gene/environment interaction. 
A total of 65 New Zealand white rabbits (Oryctolagus cuniculus) were used. Forty one 
(41) rabbits with delayed onset craniosynostosis were obtained, as well as 24 in-colony normal 
rabbits from a similar colony, but who did not display phenotypic expression of craniosynostosis. 
Both phenotypic groups were divided into 3 treatments groups: post-natal injections of tri-
iodothyronine (T3), vehicle sham, or control no-treatment group. A 2x3x3 (phenotype x 
treatment x age) design was used. Amalgam markers were placed around frontonasal, coronal 
and anterior lambdoid suture. Lateral and dorsoventral cephalograms were taken at 10, 25 and 42 
days. Lateral cephalograms were traced, 13 anatomic landmarks identified, and both linear and 
angular measurements were made. Correlation between treatment group and coronal suture 
marker measurement was made. 
Results showed statistically increased blood T3 levels (F = 5.96, p<0.005) and decreased 
blood T4 levels (F = 41.07; p<0.000) in T3 treated groups. Coronal suture marker separation 
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decreased in treated rabbits but was not significant (F=2.07; p NS). Mean changes in body 
weight were significant in T3 treated groups (F=6.91; p<0.002). Mean changes in total 
craniofacial length, cranial vault and length, and cranial base angle were not significant. Mean 
changes in cranial vault shape index were significant (F=5.837; p<0.006). Mean changes in 
palatal angle were significant for delayed on-set rabbits as well as T3 treated groups (F=4.535; 
p<0.05; and F=3.333; p<0.05). 
In conclusion, the effect of T3 on cranial development showed changes in cranial vault 
shape index and palatal plane angle. Decreased coronal suture marker separation was observed in 
T3 treated rabbits but not statistically significant. No gene/environment interaction was observed 
in this study and other factors affecting variable phenotypic expression should be explored. 
 
 
 
 vi 
TABLE OF CONTENTS 
PREFACE .................................................................................................................................. XII 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 CRANIOSYNOSTOSIS ...................................................................................... 1 
1.1.1 Morphologic Nomenclature ............................................................................ 5 
1.1.2 Clinical Genetic Classification ........................................................................ 6 
1.1.3 Molecular Genetic Classification ................................................................... 7 
1.2 EPIDEMIOLOGY OF CRANIOSYNOSTOSIS .............................................. 9 
1.2.1 Human Demographics and Epidemiology ..................................................... 9 
1.2.2 Diagnosis of Craniosynostosis....................................................................... 10 
1.2.3 Genetic Factors .............................................................................................. 12 
1.2.4 Environmental Factors.................................................................................. 13 
1.2.5 Vitamin D Deficiency and Rickets ............................................................... 14 
1.2.6 Teratogens ...................................................................................................... 14 
1.2.7 Hyperthyroidism ............................................................................................ 15 
1.3 AIM OF STUDY ................................................................................................ 18 
1.4 PURPOSE OF PRESENT INVESTIGATION ............................................... 19 
1.5 CLINCAL SIGNIFICANCE ............................................................................ 19 
1.6 HYPOTHESIS ................................................................................................... 20 
 vii 
2.0 MATERIALS AND METHODS .............................................................................. 21 
2.1 ACQUISITION OF SAMPLE .......................................................................... 21 
2.2 DETERMINING AFFECTION STATUS AND IMPLANTING AMALGAM 
MARKERS .......................................................................................................................... 22 
2.3 DEVELOPING THE EXPERIMENTAL MODEL ....................................... 23 
2.4 DATA ANALYSIS ............................................................................................. 24 
2.4.1 Cephalometric Data Analysis ....................................................................... 24 
2.4.2 Morphometric Data Analysis ....................................................................... 30 
3.0 RESULTS ................................................................................................................... 31 
3.1 THYROID HORMONE BLOOD LEVELS ................................................... 32 
3.2 CORONAL SUTURE MARKER SEPARATION ......................................... 36 
3.3 BODY WEIGHT ................................................................................................ 39 
3.4 LATERAL CEPHALOGRAM VISUAL DIFFERENCES ........................... 41 
3.5 TOTAL CRANIOFACIAL LENGTH ............................................................. 43 
3.6 CRANIAL VAULT HEIGHT .......................................................................... 45 
3.7 CRANIAL VAULT LENGTH.......................................................................... 46 
3.8 CRANIAL VAULT SHAPE INDEX ............................................................... 48 
3.9 CRANIAL BASE ANGLE ................................................................................ 50 
3.10 PALATAL ANGLE ........................................................................................... 52 
4.0 DISCUSSION ............................................................................................................. 55 
5.0 CONCLUSION ........................................................................................................... 59 
BIBLIOGRAPHY ....................................................................................................................... 60 
 
 viii 
LIST OF TABLES 
 
Table 1: Current Morphologic Nomenclature of craniosynostosis with phenotypic presentation 
and suture involved (Jones, 2002).   ................................................................................................. 6
Table 2: Clinical Genetic Classification: Name of syndromic disorder with identified gene(s) 
(Jones, 2002; Johnson, 2011).   ......................................................................................................... 7
Table 3: Identified genes of genetic syndromes that may involve craniosynostosis (Jones, 2002).  8
Table 4: Lateral cephalometric landmarks used in the study.   ....................................................... 25
Table 5: Number of rabbis in each group.   .................................................................................... 31
Table 6: Means of tri-iodothyronine (T3) blood levels in rabbits at 42 days of age.   ................... 32
Table 7: ANOVA statistics for tri-iodothyronine (T3) blood levels in rabbits at 42 days of age.   33
Table 8: Means of thyroxine (T4) blood levels in rabbits at 42 days of age.   ............................... 34
Table 9: ANOVA statistics for T4 blood levels  ............................................................................ 34
Table 10:  Means of coronal marker suture separation at 25 and 42 days of age.   ........................ 36
Table 11: ANOVA statistics for coronal suture marker separation at 25 and 42 days of age.   ..... 37
Table 12: Mean body weights at 25 and 42 days of age.   .............................................................. 39
Table 13: ANOVA statistics for body weights at 25 and 42 days of age.   .................................... 40
Table 14: Mean Total Craniofacial Length’s at 10, 25, and 42 days of age.   ................................ 43
Table 15: ANOVA statistics for total craniofacial length at 10, 25 and 42 days of age.   .............. 43
 ix 
Table 16: Mean values for cranial vault height at days 10, 25, and 42 days of age.   .................... 45
Table 17: ANOVA statistics for cranial vault height comparing at 10, 25, and 42 days of age.   .. 45
Table 18: Mean values for cranial vault length at days 10, 25, and 42 of age.   ............................. 46
Table 19: ANOVA statistics for cranial vault length at 10, 25, and 42 days of age   ..................... 46
Table 20: Mean values for cranial vault shape index at 10, 25, and 42 days of age.   .................... 48
Table 21: ANOVA statistics for cranial vault shape index at 10, 25 and 42 days of age.   ............ 48
Table 22: Mean values for cranial base angle at 10, 25, and 42 days of age.   ............................... 50
Table 23: ANOVA statistics for cranial base angle at 10, 25, 42 days of age.   ............................. 50
Table 24: Mean values for palatal angle at 10, 25, and 42 days of age.   ....................................... 52
Table 25: ANOVA statistics for palatal angle at 10, 25, and 42 days of age.   .............................. 53
 x 
LIST OF FIGURES 
 
Figure 1: Traced lateral cephalogram with all 13 anatomic landmarks.   ....................................... 26
Figure 2: Coronal suture (CS) on traced lateral cephalogram.   ..................................................... 27
Figure 3: Total craniofacial length identified by maximum occipital point (MOP) and prosthion 
(PR).   .............................................................................................................................................. 27
Figure 4: Total cranial vault length made by opisthion (OP) and fronto-ethmodale (FE).   .......... 27
Figure 5: Cranial Vault Shape Index made from intersecting lines of anterior lambdoid suture 
(ALS) and spheno-occipital suture (SOS) with opisthion (OP) and fronto-ethmodale (FE).   ....... 28
Figure 6: Cranial base angle from basion (BA), optic foramen (OF) and nasion (NA).   .............. 28
Figure 7: Palatal angle made by intersecting lines of basion (BA) and optic foreman (OF) with 
upper molar point (UMP) and prosthion (PR).   ............................................................................. 29
Figure 8: T3 levels significantly increased in treated rabbits.   ...................................................... 33
Figure 9: T4 levels significantly decreased in treated rabbits.  ...................................................... 35
Figure 10: Delayed on-set rabbits showed significantly decreased coronal suture marker 
separation.   ..................................................................................................................................... 37
Figure 11: Coronal suture (CS) on traced lateral cephalogram.   ................................................... 38
Figure 12: Treated rabbits with T3 show decreased body weights.   .............................................. 40
 xi 
Figure 13: Lateral cephalograms for delayed on-set (DOS) and in-colony normal (ICN) rabbits. 
Blue arrows indicate coronal Sutures. Red arrows indicate taller cranium compared to 
frontonasal process.  ....................................................................................................................... 42
Figure 14: No significant difference in craniofacial lengths amongst the groups.   ....................... 44
Figure 15: Total craniofacial length identified by maximum occipital point (MOP) and prosthion 
(PR).   .............................................................................................................................................. 44
Figure 16: No significant difference in cranial vault lengths amongst the groups.   ...................... 47
Figure 17: Cranial vault length made by opisthion (OP) and fronto-ethmodale (FE).   ................. 47
Figure 18: Cranial vault shape index decreased in both treatment groups (T3).   .......................... 49
Figure 19: Cranial vault shape index made from intersecting lines of anterior lambdoid suture 
(ALS) and spheno-occipital suture (SOS) with opisthion (OP) and fronto-ethmodale (FE).   ....... 49
Figure 20: Cranial base angle did not change amongst treatment groups.   ................................... 51
Figure 21: Cranial base angle from basion (BA), optic foramen (OF) and nasion (NA).   ............ 51
Figure 22: Decreased palatal angles were seen between the two phenotypes and the T3 groups 
with control groups (T3 rabbits had decreased palatal angles).   .................................................... 53
Figure 23: Palatal angle made by intersecting lines of basion (BA) and optic foreman (OF) with 
upper molar point (UMP) and prosthion (PR).   ............................................................................. 54
 xii 
PREFACE 
 
To my wife, Jennifer Dawn Feller, who has supported me whole-heartedly. Thank you for the 
countless days you’ve spent raising our children, putting great bread on the table, and keeping 
our family together. When I think of what you’ve given up for me, and for our family, I feel truly 
humbled. If one day you want to go to school for 7 years, I’d gladly let you:) I love you with all 
my heart, and I am always yours! 
 Thank you Dr. Mark Mooney for giving me a chance to work with amazing people and 
rabbits, to do something fun and new, and for being a mentor I will never forget; thank you for a 
lifetime dedicated to teaching the next generation! Thank you Dr. Seth Weinberg for making the 
magic happen and doing everything I’ve needed to put this together. Thank you Dr. James Cray 
for your incredible insights, challenging questions, and constant support. Thank you Dr. Richard 
Doerfler for being the best clinical orthodontic mentor a resident can have (maybe tied with Dr. 
Robert Mortimer, wouldn’t dare to leave him out). Thank you Dr. Joseph Petrone for everything; 
thank you for accepting me to the University of Pittsburgh, Department of Orthodontics; thank 
you for an incredible training and confidence to go out in the world and live; thank you for 
giving me the benefit of the doubt time and again, and supporting me all the way through. Thank 
you to my co-residents, Dr. Mark Hamanishi, Dr. Erica Harvey, and Dr. Harrison Jo, for being 
 xiii 
my friends and colleagues, for your support and laughter, and for our unforgettable and forever 
bond. Thank you PITT!  
 1 
1.0  INTRODUCTION 
1.1 CRANIOSYNOSTOSIS 
Craniosynostosis is defined as early fusion of one or more of the cranial sutures (Cohen et al. 
1993). Early cranial suture fusion may occur prior to birth (known as early on-set) or post-natally 
(known as delayed on-set synostosis) (Reddy et al. 1990; Cohen et al. 1993) inhibiting the 
growth of the skull and brain (Babler and Persing, 1982; Marsh and Vannier, 1985; Richtsmeier 
et al. 1991; Kreiborg, 1986; Sarnat, 1989). Understanding cranial sutures and their development 
may increase awareness of clinical problems and their approaches for treatment. 
The cranial vault, or neurocranium, undergoes intramembranous ossification from the 
mesenchymal tissues, and consists of part of the temporal, frontal, parietal, and portions of the 
occipital, ethmoid, and sphenoid bones. Although individual, they are adjoined to one another by 
fibrous connective tissue. The fibrous connective tissue junctions are called sutures, and in the 
head, are called cranial sutures (Gray, 2000) 
Embryologically, the neurocranium develops from a small size, which facilitates vaginal 
birth, to a much larger adult size. To allow for brain growth and development, the overlaying 
cranial vault must expand in size. Cranial vault growth begins as increased cranial pressure rises 
from brain matter growth. The pressure on the cranial vault induces tensile forces at cranial 
sutures, causing separation of the bones juxtaposed bones, which is followed by compensatory 
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growth. Cranial sutures are considered essential growth centers of the skull. The method of 
growth that occurs at sutures is by appositional bone deposition. Therefore, in order for brain 
growth to occur, these sutures must contain osteo-potential cells (brain growth relies on 
appositional growth found at the sutures between cranial vault bones), and the neighboring bones 
must not fuse to one another (Gray, 2000). After cranial growth and development is completed, 
the four primary cranial sutures (metopic, coronal, sagittal, and lambdoid; Slater, 2008) will fuse. 
The metopic suture closes during the first year of life (Cunningham, 2007). The coronal, sagittal 
and lambdoid sutures close between the third and fifth year of life (Cunningham, 2007). Other 
cranial growth locations also close after growth has ceased; such as the closure of the spheno-
occipital synchondrosis occurs between ages 15-20 (Powell, 1963; Cendekiawan. 2010); the 
spheno-ethmoidal synchondrosis closes early around 6 years of age; and the intersphenoid 
synchondrosis closes immediately after birth (Cendekiawan, 2010). 
Nevertheless, premature fusion of cranial sutures during the developmental process has 
been seen in humans, rabbits, rats, and other species (Akita, 1994; Mooney, 1994; Gardner, 
1998). Cranial suture fusion may occur due to a genetic or environmental reason (an insult 
originating from the environment of the fetus/child; such as drug, application of force, or 
behavior), or a combination of both. A common example of an environmental insult may be due 
to a mechanical condition, where reduced cranial pressure may lead to suture fusion. This is 
explained by neighboring bones approximating one another too closely and/or for too long a 
period of time that they may thereby fuse prematurely during fetal or adolescent growth and 
devolvement (Jacob, 2007). Future growth at that cranial suture will then cease.  
Cranial sutures are a type of anatomic joint. In the body, all joints are derived of three 
basic types: synarthrosis, immovable; amphiarthrosis, slightly movable; diathrosis, freely 
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movable. The bony joints in the skull are mostly synarthrotic, and no appreciable movement 
occurs (syn, lack of; arthrosis, joint). Cranial sutures belong to the synarthrotic group, and are 
joint spaces of two bones that almost meet, except for a band of connective tissue or hyaline 
cartilage. Motion is not intended at these joints. Within the synarthrotic group are four 
variations: sutura, schindylesis, gomphosis, and synchondrosis. As evident by its word, sutura 
is Latin for suture, and sutura are only found in the skull. The connective tissue separating the 
two bones of a suture is thin fibrous tissue. And among sutures, there are further categories. 
True sutures are when margins of two bones interlock together by processes and indentations, 
and three variations occur: sutura dentate, serrate, and limbosa. The biparietal bone suture 
(also known as the sagittal suture) exhibits tooth-like projections and is called sutura dentate. 
The suture between the two frontal bones (metopic suture), shows small serrated teeth, like from 
a fine saw, and is called sutura serrate. Between the frontal and parietal bones (coronal suture), 
inter-lockings occur with a degree of overlap of the entire body of a bone, and is called sutura 
limbosa. False Sutures consist of roughed borders of two bones, and placed in opposition to one 
another, but lack the interlocking processes. Of this, there are two kinds: sutura squamosa, 
which is found between temporal and parietal bones and exhibits overlapping of the two bones; 
sutura harmonia, found between the two maxillae (and palatine bones) and demonstrates 
continuous rough surfaces. (Gray, 2000) 
Other types of synarthrotic joints are gomphosis, synchondrosis, and schindylesis 
joints. Gomphosis articulations are found as the periodontal membrane connecting teeth to the 
alveolus. Synchondrosis articulations are where two adjoining bones meet with cartilage found 
between them: these articulations are considered important growth centers in the skull. 
Schindylesis articulations occur when thin laminae of bone insert perpendicularly into a 
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depression of another bone, such as the perpendicular plate of ethmoid or the vomer bone into 
the maxillae or rostrum of sphenoid bones (Gray, 2000) 
Cranial sutures may allow for movement, in spite of being part of the synarthrotic group. 
Movement at cranial sutures, particularly fontanelles (a confluence of two or more sutures; Gray, 
2000), is necessary during vaginal birth, where cranial bones may shift, and allowing passage of 
the baby. Fusion of a cranial suture will inhibit any movement at the joint. Therefore, the term 
synostosis (syn- no movement; ostosis- between boney segments) is used to describe a fused 
cranial suture; and the definition of c
Fusion of a cranial suture is a normal and physiologic result for all cranial sutures once 
normal and physiologic growth is complete. Once growth and development of the brain has 
ceased and reached maturity (brain growth plateaus at age 6, but development, such as 
myelination may continue well into 6th decade of life; Benes, 1998), fusion occurs per the 
described mechanism as previously mentioned (tensile forces no longer occur at two boney 
segments of a suture, whereby separating them, as they approximate one another they naturally 
fuse). If fusion happens pathologically at a suture, prior to the brain reaching total growth, then 
the clinical consequences can range from being non-serious and undetected, to very serious with 
craniofacial, mental, ophthalmic, auditory, or maxillofacial deformities (Gray, 2000). Just as 
clinical signs and symptoms of craniosynostosis may vary, so may vary the causes of 
craniosynostosis. Causes may range from isolated cases involving a first generation point-
mutation(s), to being part of a syndrome, or a combination of a variety of genetic and 
environmental conditions (Gray, 2000) 
raniosynostosis is a lack of movement between the two 
boney segments of a cranial suture (Gray, 2000; Kabbani, 2004; Delashaw, 1989).  
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Classification systems of craniosynostosis have evolved over the years in an attempt to 
best describe the clinical differences of craniosynostosis. In the 19th century, Otto published a 
Morphologic Nomenclature that described and differentiated the variable appearances of head 
shape. At the beginning of the 20th century, a Clinical Genetic Classification system became 
more and more common, due to the occurrence of craniosynostosis in conjunction with genetic 
syndromes, such as Apert or Crouzon. Recently, in the 1990’s, specific genes began to be 
isolated from genetic syndromes which display craniosynostosis (such as Pfeifer syndrome), and 
a separate system called Molecular Genetic Classification was developed (Wilkie, 1997; Cohen 
and MacLean, 2000). All three nomenclatures are commonly referred to today, and each has its 
role in understanding the diagnosis of craniosynostosis and etiology of its cause (Jones, 2002). 
1.1.1 Morphologic Nomenclature 
For centuries, and likely millennia, mankind has noted aberrant and dysmorphic head shapes. It 
is with little wonder that the first classification system for craniosynostosis would be based on 
Morphologic Nomenclature (see Table 1). To name a few: Dolicocephaly refers to elongated 
head appearance, and results from fusion of the sagittal suture. Acrocephaly is seen as a pointed 
head, and is a fusion of the coronal suture. Fusion of the metopic suture may be known as 
trigonocephaly. Many cases can involve unilateral or incomplete fusion of a suture, such as 
plagiocephaly. It is a fusion of a unilateral coronal suture, giving an asymmetric head 
appearance (Jones, 2002).  
 
 
 
 6 
Table 1: Current Morphologic Nomenclature of craniosynostosis with phenotypic presentation and suture 
involved (Jones, 2002). 
Term Appearance Affected Suture 
Dolicocephaly Long head Sagittal suture 
Scaphocephaly Keel-shaped head Sagittal suture 
Acrocephaly Pointed head Coronal, Coronal/Lambdoid, or all 
sutures 
Brachycephaly Short head Coronal suture 
Oxycephaly Tower-shaped head Coronal/lambdoid or all sutures 
Turricephally Tower-shaped head Coronal suture 
Plagiocephaly Asymmetric head Unilateral coronal, unilateral 
lambdoid, or positional 
Kleeblattschadel Clover-leaf skull Multiple but not all sutures 
Craniofacial dysostosis Midface deficiency Craniosynostosis with involvement of 
cranial base sutures 
1.1.2 Clinical Genetic Classification 
In cases where craniosynostosis occurs with an array of other malformations, such as Apert’s 
syndrome, an additional classification system is needed; hence the Clinical Genetic 
Classification system (see Table 2). In the 1980’s, there began to be increase in documented 
cases of craniosynostosis, and evidence was found that nearly 80% of syndromes associated with 
craniosynostosis involved malformations in the limbs. The same genes that caused limb defects 
or syndactaly in syndromes were questioned at being responsible for craniosynostosis (Jones, 
2002). 
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Table 2: Clinical Genetic Classification: Name of syndromic disorder with identified gene(s) (Jones, 2002; 
Johnson, 2011). 
 
Diagnostic Category Name of Disorder Etiology 
Isolated craniosynostosis Morphologically described Unknown, uterine constraint or 
FGFR3 or EFNA4 mutation 
Syndromic craniosynostosis Antley-Bixler syndrome POR 
 Apert syndrome Usually one of two common 
mutations in FGFR2 
 Bacre-Stevenson syndrome Mutation in FGFR2 or FGFR3 
 Baller-Gerold syndrome Mutation in TWIST heterogenous 
 Carpenter Syndrome RAB23 
 Crouzon Syndrome Numerous different mutations in 
FGFR2 
 Muenke syndrome Mutation in FGFR3 
 Pfeiffer syndrome Mutation in FGFR1 or numerous 
mutations in FGFR2 
1.1.3 Molecular Genetic Classification 
In the 1990’s, specific genes began to be identified in the syndromes that are related to 
craniosynostosis (Apert’s, Crouzon’s, Pfeifer, etc.). Mutations in FGFR1, 2 or 3 were seen in 
Pfeifer, Apert, Muenke, and other syndromes. Mutations in TWIST were seen Baller-Gerold or 
Saethre-Chotzen syndromes. Other genes have since been identified in other syndromes too. It is 
not clear how mutations in different genes and in different syndromes can cause 
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craniosynostosis, therefore a new classification for craniosynostosis was made; one based on 
Molecular Genetic Classification, see Table 3 (Jones, 2002)  
 
Table 3: Identified genes of genetic syndromes that may involve craniosynostosis (Jones, 2002). 
Gene Mutation Phenotype 
FGFR1 755C through G Pfeiffer syndrome (milder phenotype) 
FGFR2 Multiple Apert, Bacre-Stevenson, Crouzon, Jackson-
Weiss, Pfeiffer syndrome (severe phenotype) 
FGFR3 Multiple Bacre-Stevenson, Crouzonodermoskeletal, 
Muenke syndrome 
MSX2 Pro148His Boston-type synostosis 
TWIST Multiple Baller-Gerold, Saethre-Chotzen syndrome 
 
Understanding the cause of craniosynostosis has been difficult due to, in part of, the small 
number of documented cases with the disease. Many cases of craniosynostosis may go un-
noticed or unreported due to its milder forms or limitations to access of care. Furthermore, there 
may be carriers of a craniosynostotic gene who do not present with the phenotype. Not all cases 
report the same severity, indicating a variable phenotypic expression of craniosynostosis. Its 
incomplete penetrance of craniosynostosis is still unexplained. 
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1.2 EPIDEMIOLOGY OF CRANIOSYNOSTOSIS 
1.2.1 Human Demographics and Epidemiology 
Craniosynostosis occurs 1 in 2,000 to 2,500 live births worldwide and has no gender preference.  
The most commonly affected suture is the sagittal suture, occurring in about 40-55% of 
nonsyndromic cases. Coronal synostosis is the second most common type, comprising 20-25%, 
and metopic synostosis is third, comprising 5-15%. Lambdoid synostosis comprises only 0-5% 
of nonsyndromic cases. Nonsyndromic cases usually only affect one suture. When more than 
suture is affected, it is called complex craniosynostosis, and constitutes 5-15% of all cases. 
Generally they are related to syndromes (Slater, 2008) 
The pathology of craniosynostosis has been well researched (Carmichel, 2008; Gardner, 
1998; Honein, 2000; Kallen, 1999; Olshan, 1989; Jentink, 2010; Johnsonbaugh, 1978; Mulliken, 
2004; Moloney, 1997; Passos-Bueno, 2008). Possible mechanisms are that the dura mater plays a 
critical role in the patency of sutures; others say the cause lies within the periosteum and 
connective tissue of the suture. Current research evaluates the gene/molecular interactions. 
Certain genes have already been isolated (FGFR1, 2, and 3, Tgf-br I and II, TWIST, and Msx1) 
that cause syndromic abnormalities, some being craniosynostosis. Nevertheless, the same 
affected gene is not present in all the syndromes that relate to craniosynostosis. Therefore, the 
likelihood that one gene causes craniosynostosis is remote. More likely, the cause of 
craniosynostosis is a combination of genes, mechanical/ biomechanical (either increased fetal 
pressure pre-birth, or decreased cranial pressure post birth), environmental or hormonal factors 
(Jacob, 2006 and 2007). 
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1.2.2 Diagnosis of Craniosynostosis 
The diagnosis of craniosynostosis can only happen if a parent or physician suspects the clinical 
condition. It is made by from a physical examination, a review of family and personal medical 
history, and also by ultrasound or radiographic analysis. Usually diagnosis, treatment, and care 
of individuals with craniosynostosis, are performed in a craniofacial center, which usually are 
associated with major metropolitan hospitals.  
A child’s misshaped head is a common reason that brings the patient in for diagnosis of 
craniosynostosis. Nevertheless a malformed (dysmorphic) head is not the only symptom of 
craniosynostosis that worries parents and gets the attention of physicians. When a suture fuses 
(for whichever reason) but brain growth continues, there is an increase in intracranial pressure 
(ICP). Its symptoms can be quite severe (headaches, nausea, vomiting, lethargy, etc.). Children 
with craniosynostosis present with symptoms of ICP in 4-20% of cases. If more than one suture 
is involved in craniosynostosis, symptoms of ICP may be present in 62% of patients (Thompson, 
2008). 
Physical examination of a patient with craniosynostosis measures the head 
circumference, assesses for skull and limb deformities, and plots the child’s growth curve. Skull 
deformities can be assessed from a superior view (bird’s eye view), posterior view, and/or 
anterior view of the skull. Asymmetry is key to identify abnormal growth, including the eyes, 
ears, and nose in addition to overall head shape.  
Computed axial tomography (CT) is the gold standard for radiographic analysis and 
diagnosis of craniosynostosis. Single suture synostosis can be identified with 2D radiographs, 
such as dorsoventral or lateral cephalogram radiographs. But CT scans are much more effective 
at visualizing the entire skull and identifying the scope of deformity (Medina, 2000). 
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Craniosynostosis can occur prior to birth, early on-set, or after birth delayed on-set 
(Reddy et al. 1990; Cohen et al. 1993). As previously mentioned, craniosynostosis occurs 
sporadically in the population and also in families. When craniosynostosis is repeated in a family 
pedigree, it is called familial craniosynostosis, and genes are likely the cause (Cohen et al. 1993). 
If a teratogen was exposed to the entire family, an environmental condition could theoretically 
cause familial craniosynostosis. No such cases have yet been documented. Since sporadic cases 
of craniosynostosis are very few, and their causes may differ extremely, it has been easier to 
study familial craniosynostosis, either related with a syndrome or not. Sporadic cases appear to 
be more biomechanically caused, while familial CS seems to be more genetic. Nevertheless, only 
15% of familial cases have had genes identified with them.  
Familial craniosynostosis is fairly common, and many reports show that environmental 
influences in these families may increase the penetrance and/or expression of craniosynostosis 
(Kosnik et al. 1975; Hunter and Rudd, 1976 and 1977; Cohen et al. 1993; Lajeunie et al. 1995, 
1996, and 1998; Renier et al. 2000; Guimaraes-Ferreira et al. 2001). Familial craniosynostosis 
may be extremely varied amongst family members. This variable expression and phenotypic 
heterogeneity involves the number of sutures involved and timing of fusion. The variable 
expression of craniosynostosis in humans is similar to the variable expression of the rabbit 
colony used in this study (Kosnik et al. 1975; Lajeunie et al. 1995 and 1996; Moloney et al. 
1997; Beaudet et al. 2001; Mooney et al. 1994a, 1994b, 1996, 1998, 2002).  
An example of human phenotypic variability is when a parent has a mild form of a single 
synostotic suture, without mental impairment, while the child is severely affected with multiple 
suture early on-set synostosis and mental acuity impairment. Furthermore, a parent may only 
carry a gene related to craniosynostosis, but the children could show early on-set synostosis of 
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one or more suture, delayed on-set synostosis of one or more suture, or may not show any signs 
of synostosis (Kosnik et al. 1975; Hunter and Rudd, 1976 and 1977; Cohen et al. 1993; Lajeunie 
et al. 1995, 1996, and 1998; Renier et al. 2000; Guimaraes-Ferreira et al. 2001).  
It’s been suggested that the variable expression of fusion location and timing may be a 
result of either genetic or environmental factors. Genetic factors involve specific mutated 
ligands (as in the variability in different syndromes with FGFR2 mutations), Msx2 homeobox 
domain mutations, or an accumulation of modifier genes (i.e., inbreeding) (Muller et al. 1993; 
Jabs et al. 1993; Liu et al. 1995; Steinberger et al. 1996; Moloney et al. 1997; Reardon et al. 
1997; Gripp et al. 1998; Renier et al. 2000; Cohen and MacLean, 2000; Cray, 2010). 
Environmental factors such as perinatal exposure (exogenous or endogenous) to teratogens or 
endocrine influences like androgens, insulin, or thyroid hormones (Friedman and Mills, 1969; 
Yip et al. 1980; Inouye et al. 1985; Alderman et al. 1994; Rothman et al. 1995; Gardner et al. 
1998; Lajeunie et al. 2001; Duggan et al. 1970; Cohen and MacLean, 2000; Shashi and Hart, 
2002).  Maternal hyperthyroidism from autoimmune diseases such as Grave’s disease in humans 
can result in early-onset craniosynostosis (Rasmussen, 2007). However, little is known about the 
interaction of these genes/genetic factors with environmental factors on incidence and penetrance 
of craniosynostosis. 
1.2.3 Genetic Factors 
Craniosynostosis has been related to genetic disorders. Fibroblast growth factor receptor 1, 2, or 
3, Tgf-br I and II, TWIST, and Msx2 genes have been identified in some of the syndromes 
involving craniosynostosis (see Table 3). Fibroblast growth factors and receptors are found 
throughout connective tissue, and especially in cranial sutures. They regulate bone growth both 
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pre and post-natally. Mutations in these genes can cause gain of function, resulting in abnormal 
bone deposition and fusion. TWIST genes decrease the function of FGFR and indirectly control 
bone growth. Thus mutations in TWIST genes lead to loss of function. Craniosynostosis may be 
caused by small changes in the fine balance of bone regulation. These genes impact many tissues 
in the head, and other affected cranial structures are common. Apert, Crouzon, Peiffer, etc. all 
have other craniofacial abnormalities and dental disturbances. What remains unanswered is if all 
these disturbances are individually caused by genetic mutations, or if one deformity may result in 
another deformity (Wilkie, 1997). 
1.2.4 Environmental Factors 
Craniosynostosis may result from teratogen exposure (Friedman and Mills, 1969; Yip et al. 
1980; Inouye et al. 1985; Alderman et al. 1994; Rothman et al. 1995; Gardner et al. 1998; 
Lajeunie et al. 2001), but more commonly results from a systemic metabolic disturbance 
(Duggan et al. 1970; Cohen and MacLean, 2000; Shashi and Hart, 2002).  Epidemiological and 
case studies can describe relative associations, but isolating specific environmental factors is 
difficult due to the limited number of subjects in these studies (not achieving a strong statistical 
power) and the likelihood there are multiple environmental factors (inability to control for any 
one particular) (Shashi and Hart, 2002). The CDC ran an epidemiologic study that associated 
children born to mothers with thyroid hormone therapy to have increased odds ratio of 2.5 
(Rasmussen et al. 2008). With that being said, there have been only a few environmental factors 
known to be related to craniosynostosis. Some of these are vitamin D deficiency and rickets, 
handful of teratogens, and hyperthyroidism. 
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1.2.5 Vitamin D Deficiency and Rickets  
Rickets: is a condition related to a deficiency of vitamin D insufficiency to calcify 
growing bones in adolescents (Shashi and Hart, 2002). Deficiency of vitamin D may be due to 
lack of dietary intake, resistance of vitamin D, liver disease, chronic liver failure, and 
hypophosphatasia. Each of these forms of deficiencies has been linked to craniosynostosis 
(Coleman and Foote, 1954; Fraser, 1957; Reilly et al. 1964; McCarthy and Reid, 1980; Shashi 
and Hart, 2002). Infantile hypophosphatasia has frequently observed with craniosynostosis and 
ocular proptosis (Brenner et al. 1969). In genetic cases of rickets, craniosynostosis has been 
found as a secondary characteristic (Willlis and Beaty, 1997). Roy et al developed a mouse 
model with X-linked dominant hypophosphatasia that may be useful to study the development of 
craniosynostosis (Roy et al. 1981). 
1.2.6 Teratogens 
With regards to teratogen influence in craniosynostosis, evidence has mainly been 
limited to case reports. Nevertheless, there is evidence that maternal smoking has been linked to 
increased risk of craniosynostosis.  Phenytoin exposure during pregnancy can lead to synosotosis 
of the sagittal and coronal sutures (Char et al. 1978). Metopic ridging has been observed from 
anticonvulsant treatment with valproate (Ardinger et al. 1988). Amine containing drugs 
(cyclophosphamide, alkylating agent in cancer chemotherapy) exposed to a fetus may also be 
linked to CS (Mutchinick et al. 1992; Enns et al. 1999). 
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1.2.7 Hyperthyroidism 
Increased exposure to thyroid hormone has been linked to craniosynostosis. Thyroid 
hormones, thyroxine (T4) or tri-iodothyronine (T3), are produced in the thyroid gland (Walter, 
2003). These tyrosine based hormones’ primary role is to regulate metabolism (Walter, 2003). 
Thyroxin affects nearly all cells in the body (Dratman, 1996). Thyroid hormones have been 
found to increase metabolic rate of protein, fat and carbohydrates in all cells, affect synthesis of 
protein, regulate long bone growth and neuronal development, increase body’s sensitivity to 
catecholamines, and promote vitamin metabolism (Dratman, 1996). Thyroid related conditions 
have been seen with either excess or lack of thyroid hormone production (Torre et al. 2008). 
Thyroxine (T4) is produced 20 times more than T3, and is considered more stable due to 
its longer half-life than the 2-3 day half-life of T3 (Wiersinga, 2001). Thyroxine (T4) is 
converted to tri-iodothyronine (T3) by di-iodination of 4 molecular iodines to 3 (Simonides, 
2008; Walter, 2003). Tri-iodothyronine is the most active form of thyroid hormones (Walter, 
2003). Thyroxine (T4) acts as a reservoir for T3 (Wiersinga, 2001). Conversion of T3 is 
accomplished mainly within target cells (Walter, 2003). Tri-iodothyronine (T3) has a 10-fold 
greater affinity for thyroid receptors than T4 in cells (Samuels, 1974; Bianco, 2002). 
Thyroid hormone has been found to affect the bone remodeling process. Bone 
remodeling is regulated by numerous calcitropic hormones (parathyroid hormones, sex steroids, 
thyroid hormones, etc.; Akita, 1996; Eriksen, 2010). The effect of thyroid hormones on bone 
remodeling differs at different stages of development (Akita, 1996; Eriksen, 2010; Mysliwiec, 
2007c). In children, excess thyroid hormone increases skeletal bone formation, while in adults, 
hyperthyroidism causes bone loss due to increased bone turnover rate and increased bone 
resorption (Akita, 1996). In the presence of thyrotoxicosis, normal bone remodeling process 
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decreases from 200 days to only 100 days (Eriksen, 2010). In elderly women, osteoporosis may 
be related to increased levels of interleukin-6 (IL-6) and thyrotoxicosis (Mysliwiec, 2007c). 
Interleukin-6 (IL-6) appeared to play a crucial role in thyrotoxicosis-related disturbances, mostly 
by inhibition of bone formation, in an animal study of mice (Mysliwiec, 2007a). Osteoclastic 
activity decreased in rats with hypothyroid treatment (Mysliwiec, 2007b). Decreased bone 
density has also been seen in postmenopausal women who were treated with thyroxine (Guo, 
1997).  
Hyperthyroidism, whether congenital (as in auto-immune Graves’ disease) or as a 
consequence of thyroid replacement hormone therapy, has been associated with craniosynostosis 
in numerous reports throughout the pediatric and endocrinology literature (Robinson et al. 1969; 
Duggan et al. 1970; Menking et al. 1972; Riggs et al. 1972; Penfold and Simpson, 1975; 
Hollingsworth and Mabry, 1976; Johnsonbaugh et al. 1978; Daneman et al. 1980; Floret et al. 
1980; Cove and Johnson, 1985; Leonard et al. 1987; Krude et al. 1997; Segni et al. 1999; 
Zimmerman, 1999; Bieberman et al. 2000; Shashi and Hart, 2002). Children, born from mothers 
with hyperthyroidism (hyperthyroid state due to exogenous treatment for hypothyroidism, or 
endogenous over production of thyroid hormones), have been observed with craniosynostosis 
(Leonard et al. 1987).  
 The mechanism of hyperthyroid induced craniosynostosis is not entirely clear.  While 
generalized skeletal maturation is a common finding in fetal, infant, and childhood 
hyperthyroidism (Schlesinger and Fisher, 1951; Riggs et al. 1972; Johnsonbaugh et al. 1978; 
Cove and Johnston, 1985; Schwab et al. 1996), it is believed that precocious bone maturation 
itself is not the cause of the craniosynostosis (Johnsonbaugh et al. 1978; Cohen and MacLean, 
2000).   For example, Johnsonbaugh et al. (1978) noted that in cases of congenital adrenal 
 17 
hyperplasia, bone age is typically advanced, but no association with craniosynostosis exists.  
This suggests that although thyroid hormone (TH) may increase skeletal maturation, its pathway 
to do so is different than the androgens or mineralocorticoids involved in adrenal hyperplasia. 
Thyroid hormone may act locally to stimulate sutural ossification through one or more 
designated biochemical pathways, or perhaps centrally through yet undiscovered pathways. 
Akita studied fusing sutures in a hyperthyroid rat model (Akita et al 1994, 1996). Sixty 
(60) Wistar rats, n=30 in a treatment group of tri-iodothyronine (T3), received 0.1 
microgram/gram of T3 per body weight per day starting at 10 days of age. Control group, n=30, 
were used to compare. The rats were sacrificed at 15, 30, and 60 days. Morphologic 
measurements found that lambda-asterion and pterion-bregma distances were significantly 
decreased. Histologic findings showed fluorescent labeling without interruption along the 
sutures, indicating narrowing of the sagittal suture with continuous bone formation. Tartrate 
resistant acid phosphatase staining, in the T3 treatment group, revealed little osteoclastic activity 
in the sagittal suture. Local IGF-1 was markedly increased in the suture margins. Local IGF-1 
previously has been found to play a critical role in suture formation of in vivo bone models, 
being the most abundant growth factor in osteoblasts (Krieger et al. 1988; Wolf et al. 1989; 
Lakatos et al. 1993; 2000; Thaller et al. 1993a, 1993b, and 1996; Varga et al. 1994; Klaushofer et 
al. 1995; Huang et al. 2000; Conover and Rosen, 2002; Stern, 2002). Akita concluded that excess 
administration of thyroid hormone enhanced the cranial suture closure, increased local IGF-1, 
and that local IGF-I played an important role in the sutural closure (Akita et al. 1996). Further 
studies contribute to understanding the general osteogenic role of both TH and local IGF-1 
(Canalis, 1980; Rizzoli et al. 1986; Canalis et al. 1988; Krieger et al. 1988; Wolf et al. 1989; 
Lakatos et al. 1993 and 2000; Thaller et al. 1993a and 1993c; Varga et al. 1994; Klaushofer et al. 
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1995; Linkhart et al. 1996; Wakisaka et al. 1998; Huang et al. 2000; Rizos et al. 2001; Conover 
and Rosen, 2002; Stern, 2002).  
1.3 AIM OF STUDY 
The aim of this project was to identify the environmental influence of post-natal administration 
of tri-iodothyronine (T3) in rabbits that demonstrate familial delayed onset craniosynostosis 
when compared in-colony normal control rabbits. The hypothesis was tested in a well-
established rabbit model of familial craniosynostosis with variable expression (Mooney et al. 
1994a, 1994b, 1996, 1998, 2002).  This rabbit model, similar to humans, demonstrates autosomal 
dominant transmission with incomplete penetrance (Mooney et al. 1996), and a broad range of 
phenotypic expression that includes: phenotypically normal animals that carry the mutation, 
unilaterally affected animals with postnatal or delayed-onset synostosis, animals presenting with 
complete bilateral fusion with prenatal or early-onset, or animals with severe synostosis that do 
not survive (Mooney et al. 1998).  
These rabbits possess a broad spectrum phenotype and provide a unique opportunity for 
investigating the relationship between circulating thyroid hormones and suture pathology.  In the 
presence of excess tri-iodothyronine (T3), the pattern of craniosynostotic progression in affected 
and unaffected rabbits were altered, such that changes in the timing and severity of sutural 
hyperostosis were followed.  
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1.4 PURPOSE OF PRESENT INVESTIGATION 
Since there is evidence that  pre- and post-natal exposure to maternal hyperthyroidism can affect 
suture development and patency in normal individuals (Johnsonbaugh et al. 1978; Riggs et al. 
1972; Menking et al. 1972; Hollingsworth et al. 1976; Daneman et al. 1980), it was hypothesized 
that an interaction of postnatal treatment of exogenous tri-iodothyronine (T3) and a genetic 
propensity for synostosis would accelerate suture fusion and result in more severe phenotypes in 
individuals with a synostotic phenotype compared to controls. 
In particular, it was hypothesized that a 17 day long, postnatal exposure to tri-
iodothyronine (T3) in 25 day old rabbits that have delayed-onset synostosis (typical fusion and 
plateau of cranial growth is about 42 days of age for rabbits used in this study) would result in 
more decreased coronal suture growth than treated or untreated in-colony normal control rabbits 
and untreated delayed on-set coronal suture synostotic rabbits, pointing towards a 
gene/environment interaction of T3 with affected genes found in our colony of rabbits. 
1.5 CLINCAL SIGNIFICANCE 
Certainly, humans exhibit a natural range of variation regarding thyroid hormone production 
and/or receptor affinity, and sub-clinical cases of hyperthyroidism exist (Refetoff et al. 2001).  In 
terms of treatment, individuals with sub-clinical or clinical hyperthyroidism may be at greater 
risk for craniosynostosis. Controlling thyroid hormone levels in these individuals may mitigate 
the risk of post-operative re-synostosis may follow suturectomy (Moss, 1959; Norwood et al. 
1974; Marchac and Renier, 1982, Marsh and Vannier, 1985; Ousterhout and Vargervic, 1987; 
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Persing et al. 1989; Hassler and Zentner, 1990; Fatah et al. 1992; Drake et al. 1993; Hudgins et 
al. 1998; Jane and Persing, 1986; Mooney et al. 2001). 
1.6 HYPOTHESIS 
Postnatal exogenous hyperthyroid exposure would accelerate coronal suture fusion and 
affect subsequent calvarial growth more severely in rabbits with familial delayed-onset 
synostosis than in-colony control rabbits. 
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2.0  MATERIALS AND METHODS 
Sixty five rabbits were utilized in the present study. A 2 x 3 x 3 (phenotype x treatment x age) 
design will be employed with 10 rabbits per group. The phenotype variable included), 
phenotypically normal in-colony rabbits (n=24), and rabbits with delayed onset coronal suture 
synostosis (n=41). The treatment groups included untreated controls, sham or vehicle treated 
controls, and rabbits treated with tri-iodothyronine (T3). Vehicle control treatments groups 
received buffered saline every three days from 25 days of age to 42. Surgical sham control 
groups only received amalgam markers with no further treatment. Thyroid hormone treatment 
group received 0.2mg/kg dose of tri-iodothyronine (T3) every 3 days beginning at 25 days of age 
to 42. The age variable included radiographic data collected on each rabbit at 10, 25, and 42 days 
of age.   
2.1 ACQUISITION OF SAMPLE 
A total of 65 New Zealand white rabbits (Oryctolagus cuniculus) were utilized for this study.  
Following a standardized breeding protocol (Losken et al. 1993; Mooney et al. 1994b) 41 rabbits 
with delayed-onset craniosynostosis were obtained from an existing breeding colony with 
variably expressed familial, non-syndromic coronal suture synostosis.  Twenty four (24) normal 
in-colony rabbits were obtained from the same existing breeding colony, but without coronal 
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suture synostosis.  All rabbits were housed and maintained in the Physical Anthropology 
Laboratory and Vivarium (University of Pittsburgh, Department of Anthropology).  All rabbits 
were fed a standard diet of rabbit chow and water for the duration of the experiment.  Full 
IACUC approval was obtained for this study. 
2.2 DETERMINING AFFECTION STATUS AND IMPLANTING AMALGAM 
MARKERS 
At 10 days, radiopaque suture markers were implanted to monitor suture growth.  First, rabbits 
were anesthetized with an intramuscular (IM) injection of a solution comprised of 91% Ketaset 
(ketamine hydrochloride, 100mg/ml) and 9% Rompun (xylazine hydrochloride, 20mg/ml) at a 
dose of 0.59ml/kg body weight.  Following anesthetization, hair was removed from the scalp and 
prepared with betadine and a midline incision was made with a surgical knife in the skin 
overlying the calvaria.  The skin was then undermined and reflected to facilitate visual inspection 
of the sutures.  At this point, an initial visual diagnosis was attempted for all rabbits based on 
synostotic progression.  A 0.4mm dental burr was used to make six holes in the periosteum and 
bone.  Three sets of holes were made 2mm lateral to the mid-sagittal plane on the animal’s left 
side: 2mm anterior and posterior to the coronal, frontonasal and anterior lambdoidal sutures.  
Each hole was then packed with silver amalgam to serve as radiopaque markers.  Following 
marker implantation, the skin was closed with 4-0 resorbable vicryl sutures and the rabbits were 
administered antibiotics (Baytril—Bayer Health Care LLC, from Med Vet International) through 
IM injection in order to prevent post-operative infections.  All rabbits were monitored closely to 
assure full recovery. 
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The delayed-onset rabbit model presented with gross sutural abnormalities by 25 days of 
age (Mooney et al., 1994b).  Following the initial attempt at 10 days to visually diagnose the 
rabbits, suture marker separation from radiographs (see Data Acquisition below) was used to 
confirm initial observations and diagnose DOS.  By plotting sutural growth against somatic 
growth curves, it was possible to diagnose rabbits as having slow growing or normal sutures by 
25 days of age.  Rabbits that had less than 2.2mm of bilateral coronal marker separation were 
given the diagnosis of delayed on-set craniosynostosis. Those that had more than 2.2mm 
bilaterally were diagnosed as normal rabbits. 
2.3 DEVELOPING THE EXPERIMENTAL MODEL 
Following diagnostic confirmation at 25 days of age, rabbits within each of the 2 phenotypes (in-
colony normal and delayed onset synostosis rabbits) were also randomly assigned to one of the 
three treatment groups.  These three groups included: 1) no-treatment controls, 2) vehicle 
injection control group (sham), and 3) administered tri-iodothyronine (T3). For 17 days, 
beginning at 25 days of age, rabbits in the treatment groups received subcutaneous injections 
every three days of tri-iodothyronine (half-life 2-3 days, Wiersinga, 2001) dissolved in 
water/ethanol solution, buffered with sodium hydroxide, at a dose of 200 μg/kg body weight 
similar to therapeutic hormone replacement dose for hypothyroidism (Tremblay et al. 1977; 
Banerjee, 1983; Chizzonite et al. 1984; Sadiq et al. 1985; Saeki et al. 1987; Seiden et al. 1989; 
Goto et al. 1990; Szymanska et al. 1991; Boerth and Artman, 1996; Jiang et al. 2000; Ozdemirci 
et al. 2001). Rabbits in the vehicle injection control (sham) group likewise received treatments 
for 17 days beginning at day 25, and every third day through 42 days. These injections only 
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contained the saline solution without tri-iodothyronine.  Serum T3 and T4 levels were taken at 42 
days from the marginal ear vein with a 25 gauge butterfly needle, and analyzed by enzyme 
immunoassay (AHDC Endocrinology Laboratory, Cornell University, Ithaca, NY). All treatment 
ended when the rabbits reached 42 days of age.  The treatment period, between 25 and 42 days, 
was chosen because it is characterized by rapid somatic and craniofacial growth. Data collection 
stopped at 42 days of age due to craniofacial growth plateau at 42 days of age for New Zealand 
white rabbits. 
2.4 DATA ANALYSIS 
2.4.1 Cephalometric Data Analysis 
For each rabbit, serial body weights were recorded and both lateral and dorsoventral radiographs 
of the calvaria were carried out at 10, 25, and 42 days of age.  During the dorsoventral 
radiograph the forepaw of each animal was positioned for assessment of somatic skeletal growth.  
Following a standardized protocol (Mooney et al., 1993), each rabbit was tranquilized with an 
IM injection of Ketaset (ketamine hydrochloride, 100mg/ml) at a dose of 10mg/kg body weight.  
Following tranquilization, the heads were positioned in a specially designed cephalostat.  All 
radiographs were carried out on a Phillips Oralix 70 x-ray unit at an exposure of 50kV, 7mA for 
0.17 to 0.50 seconds, with a constant tube to cassette distance of 152cm (Phillips and Company, 
Washington, DC) 
Once the radiographs were acquired, each was viewed after being scanned digitally using 
a Kodak Point of Care CR 120 and stored as image files on a Gateway 2000 PC (Eastman Kodak 
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Company, Rochester, NY).  Using the image-measuring program Scanpro (Jandel Scientific), 
amalgam marker separation (a measure of growth at the suture site) at the coronal, frontonasal 
and lambdoidal sutures was quantified.  
Cephalometric landmarks (13; see table 4, figure 1) used in previous studies on lateral 
cephalometric (Mooney et al., 1994a, 1994b), were identified by one operator for all radiographs 
from all time points (see table). Results were obtained from linear measurement of coronal suture 
marker separation (figure 2), total craniofacial length (figure 3), cranial vault length (figure 4), 
cranial vault height, and cranial vault shape index (figure 5). Angular measurements obtained 
were cranial base angle (figure 6) and palatal angle (figure 7). Other results were reported for 
blood serum levels of T3 and T4 and body weight. 
Table 4: Lateral cephalometric landmarks used in the study. 
Landmark  Abbreviation  Definition  
Opisthion  OP  Inferior tip of the occipital bone at the foramen magnum.  
Maximum occipital point  MOP  Most posterior projecting point on the occipital bone.  
Anterior lambdoid suture  ALS  Point demarcating the center of the anterior lambdoid 
suture between the osteogenic fronts.  
Coronal suture  CS  Point demarcating the center of the anterior coronal 
suture between the osteogenic fronts.  
Frontonasal suture  FNS  Point demarcating the center of the anterior frontonasal 
suture between the osteogenic fronts.  
Rhinion  RH  Most anterior point on the nasal bone.  
Prosthion  PR  Point where the alveolar bone of the maxilla meets the 
anterior surface of the upper incisor.  
Upper molar point  UMP  Point where the alveolar bone of the maxilla meets the 
anterior surface of the first molar.  
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Basion  BA  The posterior tip of the basiocciput at the foramen 
magnum.  
Spheno-occipital 
synchondrosis  
SOS  Point demarcating the center of the articulation between 
the sphenoid and occipital bones on the endocranial 
surface.  
Optic foramen  OF  Anatomical center of the optic foramen.  
Pre-spheno-ethmoidal 
synchondrosis  
PSES  Point demarcating the center of the articulation between 
the presphenoid (sphenoid) and ethmoid bones on the 
endocranial surface  
Fronto-ethmoidale  FE  Point where the cribriform plate of the ethmoid articulates 
with the frontal bone on the endocranial surface 
  
 
Figure 1: Traced lateral cephalogram with all 13 anatomic landmarks.  
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Figure 2: Coronal suture (CS) on traced lateral cephalogram. 
 
Figure 3: Total craniofacial length identified by maximum occipital point (MOP) and prosthion (PR). 
 
Figure 4: Total cranial vault length made by opisthion (OP) and fronto-ethmodale (FE). 
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Figure 5: Cranial Vault Shape Index made from intersecting lines of anterior lambdoid suture (ALS) and 
spheno-occipital suture (SOS) with opisthion (OP) and fronto-ethmodale (FE). 
 
 
Figure 6: Cranial base angle from basion (BA), optic foramen (OF) and nasion (NA). 
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Figure 7: Palatal angle made by intersecting lines of basion (BA) and optic foreman (OF) with upper molar 
point (UMP) and prosthion (PR). 
 
To assess intra-observer reliability, the entire set of landmarks was collected twice by a 
single rater from the lateral and dorsovental images of 13 animals. At least 48 hours separated 
the first and second landmarking sessions. The coordinate locations associated with each 
landmark (x-axis, y-axis) were saved and compared statistically across the two sessions by 
calculating intraclass correlation coefficients (ICCs: two-way mixed model with absolute 
agreement). This approach allows for reliability to be assessed for each landmark, in each axis 
separately. The average ICC across all landmarks in both axes was 0.999 (range: 0.989 – 1.000), 
indicating that observer-related measurement error was extremely low for all landmarks in all 
axes. 
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2.4.2 Morphometric Data Analysis 
Differences in all linear dimensions and mean measurements were assessed both within and 
across groups with a two-way ANOVA at each age group.  Post-hoc, pair wise comparisons were 
carried out with an LSD test for multiple comparisons 
 
 
 
 
 
 
 
 
 
 
 
 31 
3.0  RESULTS 
A total of 24 in-colony normal rabbits were included in this study as well as 41 delayed onset 
rabbits (See Table 5). The wild-type rabbits first enrolled in the study did not provide usable data 
and were too few in number to include in the results. Results for the delayed onset and in-colony 
normal rabbits are as follows: 
 
Table 5: Number of rabbis in each group. 
 
 
 
 
 
 
 
 
 
 
 
 
 Control Vehicle T3 
ICN 8 10 6 
DOS 14 14 13 
 32 
3.1 THYROID HORMONE BLOOD LEVELS 
Results of blood serum levels for tri-iodothyronine (T3) and thyroxine (T4) are represented in 
units of ng/ml and ug/ml respectively and are presented in Figures 8 and 9. Results show that 
mean T3 levels were significantly elevated in the delayed on-set and in-colony normal rabbits 
treated with T3 when compared to the control no-treatment or vehicle-control groups (F = 5.96, 
p<0.005, see tables 6 and 7, and figure 8). There was no statistical difference between levels of 
T3 between the treated groups (F = 0.31; p NS). Furthermore, there were no statistical 
differences in the control groups of either the delayed on-set or in-colony normal rabbits, 
meaning the untreated groups were not different from the colony as a whole (F + 0.003; p NS).  
 
Table 6: Means of tri-iodothyronine (T3) blood levels in rabbits at 42 days of age. 
 42 Days 
Mean SD 
In-Colony Normal Control 1.040 0.303 
 Vehicle 1.153 0.207 
 Surgery 2.273 2.188 
Delayed Onset Control 0.983 0.297 
 Vehicle 1.140 0.177 
 Surgery 2.827 2.690 
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Table 7: ANOVA statistics for tri-iodothyronine (T3) blood levels in rabbits at 42 days of age. 
 42 Days 
F Value P Value 
Phenotype 1.702 0.198 
Treatment 4.534 0.015 
Phenotype*Treatment 2.354 0.105 
 
 
 
 
Figure 8: T3 levels significantly increased in treated rabbits. 
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Mean levels of T4 were significantly lowered in both treatment groups (delayed on-set 
rabbits or in-colony normal rabbits) (F = 41.07; p<0.000, see tables 8 and 9, and Figure 9). There 
were no statistical differences of T4 levels between the two treated groups (F = 0.34; p NS). 
There were no varying levels of T4 between the control groups of either phenotype, delayed on-
set or in-colony normal (F = 0.42; p NS).  
 
Table 8: Means of thyroxine (T4) blood levels in rabbits at 42 days of age. 
 42 Days 
Mean SD 
In-Colony Normal Control 1.825 0.637 
 Vehicle 1.984 0.473 
 Surgery 0.064 0.931 
Delayed Onset Control 1.513 0.646 
 Vehicle 1.971 0.885 
 Surgery 0.047 0.008 
 
Table 9: ANOVA statistics for T4 blood levels 
 42 Days 
F Value P Value 
Phenotype 0.420 0.520 
Treatment 41.063 0.000 
Phenotype*Treatment 0.340 0.714 
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Figure 9: T4 levels significantly decreased in treated rabbits. 
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3.2 CORONAL SUTURE MARKER SEPARATION 
Figure 4 shows the coronal suture marker separation means by phenotype and control group. 
Visual separation of the treated groups from their control groups is apparent, indicating a trend 
towards effect. Coronal suture marker separation was measured from amalgam marker on either 
side of the suture (see Figures 10 and 11). Coronal suture marker separation between both 
phenotypes was significantly different, with the delayed on-set rabbits showing statistically 
significantly (F = 32.81; p<0.000; see Tables 10 and 11) less coronal suture growth than the in-
colony normal rabbits. Rabbits treated with T3 showed less coronal suture marker separation 
from 25 to 42 days of age however, this was not statistically different compared to controls (F = 
2.07; p NS) nor was there a statistically significant difference among any one phenotype’s three 
sub-treatment groups (F = 0.65; p NS).  
 
Table 10:  Means of coronal marker suture separation at 25 and 42 days of age. 
 25 Days 42 Days 
Mean SD Mean SD 
In-Colony Normal Control 2.650 0.24 4.044 0.44 
 Vehicle 2.655 0.61 4.325 0.70 
 Surgery 2.617 0.24 3.650 0.27 
Delayed Onset Control 1.643 0.58 2.971 0.87 
 Vehicle 1.775 0.40 3.135 0.73 
 Surgery 1.892 0.35 2.941 0.39 
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Table 11: ANOVA statistics for coronal suture marker separation at 25 and 42 days of age. 
 25 Days 42 Days 
F Value P Value F Value P Value 
Phenotype 54.569 0.000 32.808 0.000 
Treatment 0.273 0.762 2.067 0.136 
Phenotype*Treatment 0.441 0.646 0.648 0.527 
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Figure 10: Delayed on-set rabbits showed significantly decreased coronal suture marker 
separation. 
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Figure 11: Coronal suture (CS) on traced lateral cephalogram. 
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3.3 BODY WEIGHT 
Figure 5 shows mean changes in body weight by phenotype and control group. There were no 
statistical differences in body weight of any rabbits in any of the groups at age of 25 days (see 
Table 12 and 13). At 42 days of age, both treatment groups of T3 show markedly (see Figure 12) 
reduced body weights of the rabbits when compared to the control rabbits in control groups (F = 
6.91; p<0.002). There were no statistical differences in rabbit body weights between control 
groups amongst the phenotype groups, nor between the two treatment groups in either phenotype 
group. 
Table 12: Mean body weights at 25 and 42 days of age. 
 25 Days 42 Days 
Mean SD Mean SD 
In-Colony Normal Control 0.340 0.057 0.984 0.082 
 Vehicle 0.335 0.057 0.954 0.074 
 Surgery 0.310 0.081 0.733 0.095 
Delayed Onset Control 0.418 0.041 0.862 0.062 
 Vehicle 0.388 0.036 0.966 0.065 
 Surgery 0.378 0.047 0.655 0.065 
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Table 13: ANOVA statistics for body weights at 25 and 42 days of age. 
 25 Days 42 Days 
F Value P Value F Value P Value 
Phenotype 1.086 0.343 1.060 0.308 
Treatment 0.273 0.762 6.910* 0.002* 
Phenotype*Treatment 0.287 0.885 0.483 0.632 
 
 
Figure 12: Treated rabbits with T3 show decreased body weights. 
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3.4 LATERAL CEPHALOGRAM VISUAL DIFFERENCES 
Figure 13 represents six lateral cephalograms of in-colony normal rabbits and delayed on-set 
rabbits (DOS). A blue arrow visualizes the coronal suture, and coronal suture in the Normal, No 
Treatment rabbit is visually wider than the treatment (T3) rabbits. A red arrow demonstrates a 
slope from the frontonasal prominence towards the cranial vault. This visually demonstrates a 
different cranial vault shape in treated and delayed on-set rabbits. 
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Figure 13: Lateral cephalograms for delayed on-set (DOS) and in-colony normal (ICN) rabbits. Blue arrows 
indicate coronal Sutures. Red arrows indicate taller cranium compared to frontonasal process. 
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3.5 TOTAL CRANIOFACIAL LENGTH 
Figure 14 shows mean changes of craniofacial length by phenotype and control group. 
Measurements of the total craniofacial length revealed no statistical differences between the 
phenotype groups, treatment groups, or the phenotype-treatment groups at time points 10, 25, 42 
days. See Tables 14 and 15, and Figure 14 and 15. 
 
Table 14: Mean Total Craniofacial Length’s at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 52.53 3.26 66.66 6.28 81.58 4.64 
 Vehicle 50.22 4.06 66.17 3.37 81.12 3.63 
 Surgery 52.82 2.38 67.75 4.49 80.17 5.35 
Delayed Onset Control 52.01 2.98 65.71 1.99 80.42 2.57 
 Vehicle 51.94 3.71 66.76 3.86 81.52 3.59 
 Surgery 51.87 2.61 66.09 3.51 79.26 3.62 
 
Table 15: ANOVA statistics for total craniofacial length at 10, 25 and 42 days of age. 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 0.006 0.939 0.317 0.576 0.216 0.645 
Treatment 0.768 0.470 0.109 0.897 0.670 0.518 
Phenotype*Treatment 0.769 0.470 0.364 0.697 0.195 0.824 
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Figure 14: No significant difference in craniofacial lengths amongst the groups. 
 
Figure 15: Total craniofacial length identified by maximum occipital point (MOP) and prosthion (PR). 
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3.6 CRANIAL VAULT HEIGHT 
Measurements for cranial vault height were not significant for phenotype or treatment group at 
10, 25 or 42 days of age. See Tables 16 and 17. 
 
Table 16: Mean values for cranial vault height at days 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 19.26 0.62 22.13 1.00 24.79 0.66 
 Vehicle 18.71 1.03 21.78 0.84 23.56 0.70 
 Surgery 19.40 0.86 22.11 1.25 23.36 1.79 
Delayed Onset Control 19.05 1.11 21.78 1.04 23.87 1.15 
 Vehicle 19.11 0.75 21.76 1.08 23.67 1.04 
 Surgery 19.19 0.85 21.87 0.74 23.94 1.34 
 
Table 17: ANOVA statistics for cranial vault height comparing at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 0.097 0.756 0.405 0.528 0.054 0.817 
Treatment 1.020 0.295 0.222 0.802 1.598 0.216 
Phenotype*Treatment 0.486 0.618 0.108 0.897 1.301 0.284 
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3.7 CRANIAL VAULT LENGTH 
Figure 16 represents changes in cranial vault means by phenotype and treatment group. 
Measurements for total cranial vault length were not significant across phenotype or treatment 
groups for time points 10 day, 25 day and 42 day. See Tables 18 and 19, and Figures 16 and 17. 
 
Table 18: Mean values for cranial vault length at days 10, 25, and 42 of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 35.91 2.21 41.76 3.58 47.74 1.83 
 Vehicle 34.29 2.16 42.09 1.54 47.85 1.73 
 Surgery 35.69 1.61 41.88 1.78 46.55 2.60 
Delayed Onset Control 35.13 1.81 41.03 0.99 47.07 1.75 
 Vehicle 35.74 2.29 42.25 1.80 48.02 1.43 
 Surgery 35.36 1.92 41.53 2.03 46.60 2.12 
 
Table 19: ANOVA statistics for cranial vault length at 10, 25, and 42 days of age 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 0.032 0.860 0.253 0.618 0.064 0.801 
Treatment 0.346 0.710 0.649 0.528 1.859 0.170 
Phenotype*Treatment 1.454 0.245 0.213 0.809 0.194 0.824 
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Figure 16: No significant difference in cranial vault lengths amongst the groups. 
 
 
Figure 17: Cranial vault length made by opisthion (OP) and fronto-ethmodale (FE). 
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3.8 CRANIAL VAULT SHAPE INDEX 
Figure 18 represents changes in cranial vault shape index means by phenotype and treatment 
group. Measurements taken for the cranial vault shape index were all insignificant with the 
exception at 42 days of age for the treatment groups compared to respective control groups (F = 
5.837; p<0.006). See Tables 20 and 21, and Figures 18 and 19. 
 
Table 20: Mean values for cranial vault shape index at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 53.75 2.76 53.13 2.51 51.96 1.02 
 Vehicle 54.64 2.41 51.80 2.38 49.29 1.95 
 Surgery 54.43 3.06 52.78 0.92 50.16 2.24 
Delayed Onset Control 54.25 1.73 53.08 1.80 50.70 1.44 
 Vehicle 53.58 2.60 51.53 2.21 49.28 1.86 
 Surgery 55.17 3.13 52.71 1.82 51.36 1.32 
 
Table 21: ANOVA statistics for cranial vault shape index at 10, 25 and 42 days of age. 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 0.006 0.940 0.037 0.849 0.002 0.968 
Treatment 0.342 0.712 2.040 0.144 5.837 0.006* 
Phenotype*Treatment 0.614 0.546 0.013 0.987 1.433 0.251 
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Figure 18: Cranial vault shape index decreased in both treatment groups (T3). 
 
 
Figure 19: Cranial vault shape index made from intersecting lines of anterior lambdoid suture (ALS) 
and spheno-occipital suture (SOS) with opisthion (OP) and fronto-ethmodale (FE). 
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3.9 CRANIAL BASE ANGLE 
Figure 20 represents changes in cranial base angle means by phenotype and treatment group. No 
significant changes in mean cranial base angles were seen between phenotype or treatment 
groups across time points 10 days, 25 days, or 42 days. See Tables 22 and 23, and figures 20 and 
21. 
 
Table 22: Mean values for cranial base angle at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 178.56 1.16 176.10 1.74 175.56 4.32 
 Vehicle 174.81 3.84 177.94 1.60 177.62 1.52 
 Surgery 175.44 3.41 179.30 0.43 176.87 2.20 
Delayed Onset Control 175.84 2.91 175.96 3.10 178.36 1.50 
 Vehicle 176.53 2.99 176.16 2.41 175.34 4.00 
 Surgery 177.07 2.16 176.99 1.21 176.54 3.41 
 
Table 23: ANOVA statistics for cranial base angle at 10, 25, 42 days of age. 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 0.057 0.813 4.230 0.046 0.005 0.946 
Treatment 1.168 0.321 2.700 0.080 0.094 0.910 
Phenotype*Treatment 2.792 0.072 0.807 0.453 2.579 0.089 
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Figure 20: Cranial base angle did not change amongst treatment groups. 
 
 
 
Figure 21: Cranial base angle from basion (BA), optic foramen (OF) and nasion (NA). 
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3.10 PALATAL ANGLE 
Figure 22 represents changes in palatal angle means by phenotype and treatment group. 
Measurements taken for palatal angle revealed significant changes in 42 day rabbits in the 
delayed on-set rabbits and also both treatment T3 groups (F = 4.535; p<0.05; and F = 3.333; 
p<0.05). Other measurements taken at time points 10 days and 25 days or between the 
phenotype-treatment groups did not show any significant differences. See Tables 24 and 25, and 
Figures 22 and 23. 
Table 24: Mean values for palatal angle at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
Mean SD Mean SD Mean SD 
In-Colony Normal Control 128.82 3.08 129.22 2.27 125.10 0.98 
 Vehicle 129.15 2.94 128.89 2.76 124.87 2.49 
 Surgery 128.29 4.37 128.59 3.09 122.96 4.44 
Delayed Onset Control 129.14 3.86 131.43 2.89 127.77 2.33 
 Vehicle 131.77 4.22 130.45 2.94 127.58 4.06 
 Surgery 129.63 3.44 129.03 2.82 123.98 2.89 
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Table 25: ANOVA statistics for palatal angle at 10, 25, and 42 days of age. 
 10 Days 25 Days 42 Days 
F Value P Value F Value P Value F Value P Value 
Phenotype 1.626 0.209 2.226 0.144 4.535 0.040* 
Treatment 0.956 0.392 0.775 0.468 3.333 0.046* 
Phenotype*Treatment 0.436 0.650 0.265 0.768 0.291 0.749 
 
 
Figure 22: Decreased palatal angles were seen between the two phenotypes and the T3 groups with control 
groups (T3 rabbits had decreased palatal angles). 
 
 
 
 
 54 
 
Figure 23: Palatal angle made by intersecting lines of basion (BA) and optic foreman (OF) with upper molar 
point (UMP) and prosthion (PR). 
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4.0  DISCUSSION 
This study consisted of 65 rabbits from a colony that demonstrates similar phenotypic variability 
of craniosynostosis to humans. There were 24 in-colony normal rabbits and 41 with delayed on-
set craniosynostosis. It was hypothesized that post-natal administration of exogenous tri-
iodothyronine (T3) would result in decreased sutural growth than control rabbits in normal or 
delayed on-set groups.  It was further hypothesized that an interaction of the postnatal treatment 
of exogenous tri-iodothyronine (T3) and a genetic propensity for synostosis would accelerate 
suture fusion and result in more severe phenotypes in individuals with a synostotic genotype 
compared to controls. 
Results demonstrated that administration of tri-iodothyronine (T3) elevated blood 
circulating levels of T3 in treatment groups of delayed on-set and in-colony normal rabbits 
compared to control rabbits. Elevated T3 levels were achieved indicating possible thyrotoxicosis, 
but in order to diagnosis the rabbits as truly hyperthyroid, it would require clinical assessments 
and measurements that were not monitored in this study (appetite, physical stamina, etc.) as well 
as metacarpal growth measurements. Body weights were taken on the rabbits, and treated rabbits 
with T3 showed significantly decreased body weight compared to control rabbits, which may 
indicate that the rabbits might be hyperthyroid. In order to know for certain that the body weights 
decreased due to administered T3, it would be necessary to identify the somatic growth for each 
rabbit. This would rule out any low weights due to normal variation in somatic growth rate of the 
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rabbits (assuming chronologic dates of the rabbits do not indicate actual growth status). 
Decreased T4 levels in treated rabbits show that the rabbits’ endocrine response received a 
negative feedback from administered T3 levels, shutting off endogenous T4 production which 
also supports that the T3 treated rabbits exhibited thyrotoxicosis. 
The effects of T3 on treated rabbits resulted in decreased body weights, decreased cranial 
vault shape index, and decreased palatal angle. What wasn’t significant, were any changes in 
total coronal marker separation, total cranial length, total cranial height, total craniofacial length, 
and cranial base angle. Even though changes in coronal marker separation were not significant 
by treatment, the differences between the phenotypes were significant, indicating that delayed 
on-set rabbits demonstrate less coronal suture growth than their in-colony normal littermates. 
Although, administration of T3 to either DOS or ICN did not produce significantly different 
marker separation from control groups, there was a trend towards decreased marker separation 
that is visually noted in Figure 4. Due to the small sample size of each treatment group, the 
relative late administration of T3, and the small treatment effect, the significance of the treatment 
outcome could be compromised. Perhaps, increasing the sample size, and thereby increasing the 
power of the study, would result in statistical significance. Decrease in the coronal marker 
separation would foretell reduced anterior-posterior growth of the cranium, thereby requiring 
compensatory growth in other dimensions. Cranial esthetic disturbances would be likely, in 
addition to an impact on mental acuity, eyes, etc. 
A decrease in coronal marker separation is not the only variable that could indicate a 
change in the cranial growth pattern, since a decrease of growth in one suture could likely 
involve compensatory growth in another suture. Coronal marker separation was only slightly 
(not significantly) reduced from T3 administration, and there are other variables that did show 
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significant growth changes in treatment groups when compared to control groups. A decrease in 
the cranial vault shape index means that the ratio of total cranial length/total cranial height has 
decreased. That means that total cranial height (TCH) increased, while the total cranial length 
(TCL) decreased. Both these variables (TCH, TCL) were not significantly changed of 
themselves, but their subtle differences found in their ratio were significant. This change of 
growth pattern, towards an increased superior-inferior pattern, is consistent with decreased 
coronal suture growth and decreased anterior-posterior growth (see Figure 13).  
Although there was a decrease in the cranial vault shape index, suggesting an increased 
cranial height, there was not an increase in the craniofacial length. This may be due to the fact 
that the craniofacial length in rabbits is comprised of their cranium and snout, including the 
frontonasal growth apparatus. The phenotypic presentation of craniosynostosis in the colony of 
rabbits used in this study involves primarily the coronal suture, and no other cranial sutures. That 
means the frontonasal suture is not affected, and growth of the frontonasal suture should be 
uninhibited. Thus, craniofacial length would not be as grossly affected as the isolated measure of 
total cranial length (TCL). Given that the TCL was not statistically reduced in this study, it 
would lead one to expect that the craniofacial length would also not be reduced (as was observed 
in this study). 
A decrease in cranial base angle was not observed in this study, but a decrease of the 
palatal plane angle was observed. A severely affected rabbit with coronal synostosis would show 
exacerbated cranial growth compensations, including a rotation of the cranial base angle and 
likely mid-face disturbances seen in the maxilla. Treated rabbits with T3 in this study did show a 
change of the palatal plane angle. And although a similar significant change in the cranial base 
angle was not observed, that change may exist in a study with an increased sample size.  
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Change in the cranial growth pattern from administration of T3 has shown an impact in 
the 2-dimensional variables measured on the lateral cephalograms. In order to further investigate 
the impact of thyroid hormones on the cranial development, measuring the change in 
bizygomatic width from dorsoventral radiographs would elucidate a change in a different 2-
dimensional plane, of the cranial growth disturbances from administered T3. Ideally, growth 
studies of administered exogenously T3 would further benefit from 3-dimensional diagnostic 
imaging that could better relate to the clinical presentation of craniosynostosis.   
The effects of exogenously administered thyroid hormone, in the case of this study tri-
iodothyronine (T3), had no statistical difference between the two phenotypes. We observed 
decreased body weights for T3 treated delayed on-set rabbits in-colony normal rabbit groups. 
However, the difference between the two treatment effects in these two groups was not 
statistically significant. This indicates that there was no gene-environment interaction of T3 on 
the gene(s) that are causing coronal synostosis in this colony of rabbits. A gene interaction could 
still exist due to two confounding variables in this study: 1) the in-colony normal rabbits are 
genetically similar to the delayed on-set rabbits, and that a gene-environment interaction is 
occurring in both phenotypes. The gene in question could be either the same or different gene (s) 
than the gene(s) causing synostosis. Including a wild type liter into the study would control for 
the genetic presentation of the in-colony rabbits: 2) the statistical differences between the two 
treatment groups are currently not significant, but if the sample size increased to account for a 
power suitable for the treatment effect, then a gene-environment interaction between the two 
phenotypes be observed. 
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5.0  CONCLUSION 
It appears the dosage used of T3, 0.2mg/kg, created a thyrotoxicosis in the rabbits, as 
seen by the increased T3 blood serum levels, the decreased levels of circulating endogenous T4, 
and the decreased body weights following treatment. The effect of T3 on cranial development 
showed changes in cranial vault shape index and palatal plane angle. Although the decreased 
coronal suture marker separation observed in T3 treated rabbits was not statistically significant, 
that separation may become significant with an increased sample size. No gene/environment 
interaction was observed in this study and other factors affecting variable phenotypic expression 
should be explored. 
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